Robert Daniels
Amministratore Delegato presso Elastagen Pty Ltd.
Profilo
Robert Daniels is currently the Chief Executive Officer & Director at Elastagen Pty Ltd.
and a Venture Partner at Brandon Capital Partners Pty Ltd.
He previously worked as the Vice President-Asia Pacific at PharmaVentures Ltd.
and as the Chief Commercial Officer at NovaThera Ltd.
Dr. Daniels holds a doctorate degree from University College London and a graduate degree from the Australian Graduate School of Entrepreneurship.
Posizioni attive di Robert Daniels
| Società | Posizione | Inizio |
|---|---|---|
Elastagen Pty Ltd.
 Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Amministratore Delegato | 20/01/2010 |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investitore di Private Equity | 01/08/2021 |
Precedenti posizioni note di Robert Daniels
| Società | Posizione | Fine |
|---|---|---|
PharmaVentures Ltd.
 PharmaVentures Ltd. Investment ManagersFinance Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
NovaThera Ltd.
 NovaThera Ltd. BiotechnologyHealth Technology NovaThera Ltd. produces biological products and services. The firm specializes in pioneering applications of biomaterials and stem cell biology for regenerative medicine and tissue engineering to provide innovative therapeutic solutions. The company is headquartered in Cambridge, UK | Corporate Officer/Principal | - |
Formazione di Robert Daniels
| University College London | Doctorate Degree |
| Australian Graduate School of Entrepreneurship | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
PharmaVentures Ltd.
PharmaVentures Ltd. Investment ManagersFinance Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom. | Finance |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
NovaThera Ltd.
NovaThera Ltd. BiotechnologyHealth Technology NovaThera Ltd. produces biological products and services. The firm specializes in pioneering applications of biomaterials and stem cell biology for regenerative medicine and tissue engineering to provide innovative therapeutic solutions. The company is headquartered in Cambridge, UK | Health Technology |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Health Technology |
- Borsa valori
- Insiders
- Robert Daniels